Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, vol.82, issue.7037, pp.1093-1097, 2005. ,
DOI : 10.1084/jem.164.1.280
Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, vol.139, pp.1148-1152, 2005. ,
DOI : 10.1038/nm0703-847
Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques, Retrovirology, vol.6, issue.1, p.106, 2009. ,
DOI : 10.1186/1742-4690-6-106
Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine, Science, vol.270, issue.5239, pp.1197-1199, 1995. ,
DOI : 10.1126/science.270.5239.1197
HIV/AIDS: in search of an animal model, Trends in Biotechnology, vol.25, issue.8, pp.333-337, 2007. ,
DOI : 10.1016/j.tibtech.2007.05.004
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy, Nature Medicine, vol.3, issue.1, pp.76-81, 2000. ,
DOI : 10.1038/8394
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy, New England Journal of Medicine, vol.337, issue.11, pp.734-739, 1997. ,
DOI : 10.1056/NEJM199709113371102
Perils at mucosal front lines for HIV and SIV and their hosts, Nature Reviews Immunology, vol.32, issue.10, pp.783-792, 2005. ,
DOI : 10.1038/nri1706
Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy, Journal of Virology, vol.77, issue.23, pp.12479-12493, 2003. ,
DOI : 10.1128/JVI.77.23.12479-12493.2003
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection, Science, vol.276, issue.5314, pp.960-964, 1997. ,
DOI : 10.1126/science.276.5314.960
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir, AIDS, vol.23, issue.4, pp.447-454, 2009. ,
DOI : 10.1097/QAD.0b013e328321302d
Virologic and Immunologic Effect of Antiretroviral Therapy on HIV-1 in Gut-Associated Lymphoid Tissue, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.26, issue.1, pp.1-7, 2001. ,
DOI : 10.1097/00126334-200101010-00001
Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis, AIDS, vol.12, issue.6, pp.597-604, 1998. ,
DOI : 10.1097/00002030-199806000-00008
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects, AIDS, vol.17, issue.1, pp.53-63, 2003. ,
DOI : 10.1097/00002030-200301030-00008
Lack of Decay of HIV-1 in Gut-Associated Lymphoid Tissue Reservoirs in Maximally Suppressed Individuals, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.43, issue.1, pp.65-68, 2006. ,
DOI : 10.1097/01.qai.0000230524.71717.14
Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue, Science, vol.274, issue.5289, pp.985-989, 1996. ,
DOI : 10.1126/science.274.5289.985
Residual Human Immunodeficiency Virus Type 1 RNA in Lymphoid Tissue of Patients with Sustained Plasma RNA of <200 Copies/mL, The Journal of Infectious Diseases, vol.177, issue.1, pp.235-238, 1998. ,
DOI : 10.1086/517362
Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue, AIDS, vol.13, issue.1, pp.1-8, 1999. ,
DOI : 10.1097/00002030-199901140-00001
Lymphoid tissue viral burden and duration of viral suppression in plasma, AIDS, vol.15, issue.12, pp.1477-1482, 2001. ,
DOI : 10.1097/00002030-200108170-00004
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure, Proceedings of the National Academy of Sciences, vol.94, issue.23, pp.12574-12579, 1997. ,
DOI : 10.1073/pnas.94.23.12574
Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine, AIDS, vol.12, issue.2, pp.167-173, 1998. ,
DOI : 10.1097/00002030-199802000-00006
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.47, issue.1, pp.238-243, 2003. ,
DOI : 10.1128/AAC.47.1.238-243.2003
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) Aids, pp.1479-1487, 2002. ,
Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis, J Pharmacol Exp Ther, vol.264, pp.899-909, 1993. ,
Role of P-glycoprotein in tissue uptake of indinavir in rat, Life Sciences, vol.79, issue.10, pp.991-998, 2006. ,
DOI : 10.1016/j.lfs.2006.05.010
The Expression of P-Glycoprotein and Cellular Kinases Is Modulated at the Transcriptional Level by Infection and Highly Active Antiretroviral Therapy in a Primate Model of AIDS, AIDS Research and Human Retroviruses, vol.19, issue.4, pp.307-311, 2003. ,
DOI : 10.1089/088922203764969500
Post-exposure prophylaxis with highly active antiretroviral therapy could not protect macaques from infection with SIV/HIV chimera, AIDS, vol.14, issue.12, pp.1864-1866, 2000. ,
DOI : 10.1097/00002030-200008180-00029
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection, Nature Medicine, vol.9, issue.7, pp.847-852, 2003. ,
DOI : 10.1038/nm0703-847
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis, AIDS, vol.21, issue.14, pp.1899-1907, 2007. ,
DOI : 10.1097/QAD.0b013e328270385a
Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles, Vaccine, vol.22, issue.27-28, pp.3535-3545, 2004. ,
DOI : 10.1016/j.vaccine.2004.03.044
Susceptibility of Human Testis to Human Immunodeficiency Virus-1 Infection in Situ and in Vitro, The American Journal of Pathology, vol.169, issue.6, pp.2094-2103, 2006. ,
DOI : 10.2353/ajpath.2006.060191
URL : https://hal.archives-ouvertes.fr/hal-00653727
Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry, Journal of Mass Spectrometry, vol.11, issue.18, pp.389-404, 2007. ,
DOI : 10.1002/jms.1176
Development and validation of a liquid chromatographic/tandem mass spectrometric assay for the quantitation of nucleoside HIV reverse transcriptase inhibitors in biological matrices, Journal of Mass Spectrometry, vol.913, issue.1, pp.9-18, 2005. ,
DOI : 10.1002/jms.752